Tim Cook says Apple is focused on appealing the Apple Watch ban, not settling with Masimo

Share via:


Apple’s patent battle with Masimo is far from over. As it stands right now, Apple is still selling the Apple Watch Series 9 and Ultra 2 in the United States, but with the contested blood oxygen feature disabled.

In a new interview today, Apple CEO Tim Cook indicated that Apple has no interest in licensing Masimo’s technology and putting the battle to rest. Instead, he said that Apple is focused on its appeal of the ITC’s ruling.

In an interview with CNBC following the release of Apple’s fiscal Q1 2024 earnings, Cook said there are a number of reasons for someone to buy the Apple Watch other than the blood oxygen feature.

“We’re focused on appeal,” Cook said in a statement spotted by AppleInsider. “There’s lots of reasons to buy the watch even without the blood oxygen sensor.”

The Apple Watch Series 9 and Ultra 2 were briefly pulled from Apple’s website and retail stores in December. For fiscal Q1 2024, Apple’s Wearables, Home, and Accessories category reported $11.95 billion in revenue, beating expectations of $11.39 billion.

Masimo CEO Joe Kiani said in the past that Apple has yet to engage in “serious discussions about a settlement” with Masimo. In other interviews, Kiani said that Masimo is open to a settlement with Apple, but “it takes two to tango.”

For the time being, you can still buy an Apple Watch Series 9 and Apple Watch Ultra 2 from third-party retailers like Best Buy and Amazon, and they will still have the blood oxygen app and features.

FTC: We use income earning auto affiliate links. More.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Tim Cook says Apple is focused on appealing the Apple Watch ban, not settling with Masimo


Apple’s patent battle with Masimo is far from over. As it stands right now, Apple is still selling the Apple Watch Series 9 and Ultra 2 in the United States, but with the contested blood oxygen feature disabled.

In a new interview today, Apple CEO Tim Cook indicated that Apple has no interest in licensing Masimo’s technology and putting the battle to rest. Instead, he said that Apple is focused on its appeal of the ITC’s ruling.

In an interview with CNBC following the release of Apple’s fiscal Q1 2024 earnings, Cook said there are a number of reasons for someone to buy the Apple Watch other than the blood oxygen feature.

“We’re focused on appeal,” Cook said in a statement spotted by AppleInsider. “There’s lots of reasons to buy the watch even without the blood oxygen sensor.”

The Apple Watch Series 9 and Ultra 2 were briefly pulled from Apple’s website and retail stores in December. For fiscal Q1 2024, Apple’s Wearables, Home, and Accessories category reported $11.95 billion in revenue, beating expectations of $11.39 billion.

Masimo CEO Joe Kiani said in the past that Apple has yet to engage in “serious discussions about a settlement” with Masimo. In other interviews, Kiani said that Masimo is open to a settlement with Apple, but “it takes two to tango.”

For the time being, you can still buy an Apple Watch Series 9 and Apple Watch Ultra 2 from third-party retailers like Best Buy and Amazon, and they will still have the blood oxygen app and features.

FTC: We use income earning auto affiliate links. More.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Accenture quarterly earnings: Accenture quarterly numbers point to strong...

India’s $254-billion technology outsourcing industry, key to helping...

Securitize proposes BlackRock BUIDL fund as collateral for Frax...

According to RWA.XYZ, BlackRock's US dollar Institutional Digital...

iPhone 17 Air suddenly makes a lot more sense...

Last week, The Wall Street Journal reported that...

Popular

Upcoming Events

Startup Information that matters. Get in your inbox Daily!